Navigation Links
Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
Date:3/4/2008

2,

respectively 19 29

Prepaid expenses and other current assets 1,064 2,300

Total current assets 18,575 20,040

Property, plant and equipment, net 1,938 2,260

Long-term investments, at fair value 2,902 -

Other assets 638 716

Total assets $24,053 $23,016

Liabilities and Stockholders' Deficit

Current liabilities:

Accounts payable $2,975 $2,401

Accrued liabilities 3,595 4,645

Current portion of convertible senior notes,

net of discounts 2,471 -

Total current liabilities 9,041 7,046

Long-term debt owed to related party 10,000 7,083

Convertible senior notes, net of discount 16,196 18,428

Other liabilities 278 360

Total liabilities 35,515 32,917

Stockholders' deficit:

Common stock 6 39

Additional paid-in capital 227,895 207,991

Accumulated deficit (239,142) (217,860)

Accumulated other comprehensive loss (221) (71)

Total stockholders' deficit (11,462) (9,901)

Total liabilities and stockholders' deficit $24,053 $23,016

(1) The condensed consolidated balance sheet at December 31, 2006 has been

derived from the audited consolidated financial statements at that

date included
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
10. Access Highlighted in Recent BusinessWeek Article
11. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...-InimexPharmaceuticals,Inc.announcedtodaythatithas... ,, Abramsbringsmorethan25yearsofdrugdiscoverya...thenuclearmedicineimagingagent,Cardiolite,andworke...er,BiomedicalResearchWorldwide.In1996,Abramsledthe...ndCEOfrom1996to2006.AnorMEDdiscoveredanddevelopedM...
(Date:11/20/2009)... , , , , , , , ...eam of scientists from Washington University in St...rbor Laboratory and Iowa State University has fini... , Click here for more information. , ... , , , , , , , ...
(Date:11/20/2009)... Novavax, Inc. (Nasdaq: ...written public offering of 6,800,000 shares of its...r share. The approximately $21 million of net pro...and commissions, will be used for preclinical stud... internal research and development programs, worki...
(Date:11/20/2009)...EDO recently announced that Dr. Dominique Hebrault...rocess Analytical Technology (PAT) in Green Chemis...09. , (PRWEB) November 20...al Technology (PAT) in Green Chemistry and Green E...cal Technology (PAT) case studies will be presente...
Breaking Biology Technology:Inimex Announces Appointment of New CEO 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Novavax Prices Public Offering of Common Stock 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2
...st completed phase of the new Children,s,Hospital ...of Pittsburgh,of UPMC officially opened its new 10...ch Center today marking the first completed phase ...han 300,000 square feet of space, the new center w...for the region. The center - double,the size of th...
... five years, WILMINGTON, Del. and HOUSTON, Oct. 2...nderson Cancer Center today announced they,have re...l and clinical,research with a view to speeding up...ancer patients., The collaboration facilitates in...th organizations to combine resources and expertis...
... November 6, 2008, SUNNYVALE, Calif., Oct. 29 Ac...er in the field of radiosurgery,announced today th...,November 6, 2008 when Accuray will release its fu...al 2009, ended September 27, 2008. While the,major...time, certain,aspects of Accuray,s quarterly repor...
Other Biology Technology:Opening Dedication of the New John G. Rangos Sr. Research Center at the New Children's Hospital of Pittsburgh of UPMC Campus in Lawrenceville 2Opening Dedication of the New John G. Rangos Sr. Research Center at the New Children's Hospital of Pittsburgh of UPMC Campus in Lawrenceville 3AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration 2AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration 3Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009 2Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009 3Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009 4
(Date:11/23/2009)...tion Society says that western lowland gorillas li... of the "mother lode" of more than 125,000 gorilla...reatened by growing humans activity in the region....forests adjacent to the southwest border of Lac Tl...that high densities of the great apes still exist ...
(Date:11/23/2009)...available for the H1N1 virus has been sent to vacc...ccination marks the first time vaccine has been se...., Iowa State University,s Hank Harris, professo...mmer and has been shipping preventive doses to swi...ral weeks., The latest vaccines were shipped to ...
(Date:11/23/2009)...shire microbiologist Louis Tisa has received two g...f the actinorhizal plants, widespread woody plants...inated soils. , The United States Department of...olecular, cellular and biomedical sciences, $399,0...he bacteria Frankia and Casuarina, an actinorhizal...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Skirball Hospice a Program of the Los Angeles Jewish Home Marks National Hospice Month by Encouraging Community Awareness of End Of Life Programs 61437 1Skirball Hospice a Program of the Los Angeles Jewish Home Marks National Hospice Month by Encouraging Community Awareness of End Of Life Programs 61437 2Skirball Hospice a Program of the Los Angeles Jewish Home Marks National Hospice Month by Encouraging Community Awareness of End Of Life Programs 61437 3ECRI Institute Issues Health Plan Watch List 3A 2010 Top 7 Technologies 3B Exclusive Insights in White Paper Available for Free Download 61435 1ECRI Institute Issues Health Plan Watch List 3A 2010 Top 7 Technologies 3B Exclusive Insights in White Paper Available for Free Download 61435 2ECRI Institute Issues Health Plan Watch List 3A 2010 Top 7 Technologies 3B Exclusive Insights in White Paper Available for Free Download 61435 3W K Kellogg Foundation Grants 2432 5 Million to Improve Access to Fresh Food and Physical Activity for Children 61433 1W K Kellogg Foundation Grants 2432 5 Million to Improve Access to Fresh Food and Physical Activity for Children 61433 2
...y 11, 2009 -- With the costs of genome sequencing ...w developed for almost anyone with access to a com...ce information, emphasis is increasingly being pla...blems, including reducing dependency on fossil fue... may be accomplished through development of improv...
...eveloped at North Carolina State University makes ...it has been removed from the animal,s body, allowi...tools and techniques for heart surgery. The machin...m to test and refine their technologies in a reali...me associated with animal or clinical trials. , ,...
...nd Copenhagen, Denmark, May 12th, 2009 / b3c newsw...p; Co. KG announces today a technological breakthr...ments from an E. coli expression system. Richter-...ss for Phase III clinical trial material using 2nd...gy developed by the Danish biotech company Upfron...
Other Biology News:A genome may reduce your carbon footprint 2'Beating' heart machine expedites research and development of new surgical tools, techniques 2NEWSLETTER: Antibody Fragment Production Breakthrough with 2nd Generation EBA 2
Agencourt SPRPlate 384 Magnet Plate from Agencourt Bioscience
SDS-OUT PRECIP. Kit from Pierce Biotechnology, Inc.
Solvent-Detergent Removal Resin from Sigma-Aldrich
Agencourt SPRPlate D - Disc Magnet Plate from Agencourt Bioscience
Biology Products: